FREDERICK ASARE: Open Payments
NPI 1821195090 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,988 in 54 payments from 10 companies in 2025. Trend: 2023 $18,193 · 2024 $28,068 · 2025 $26,988
Consulting: $25,887Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $25,887 |
| AstraZeneca Pharmaceuticals LP | 9 | $206 |
| Novo Nordisk Inc | 6 | $200 |
| Amgen Inc. | 6 | $188 |
| GlaxoSmithKline, LLC. | 10 | $186 |
| PFIZER INC. | 3 | $164 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 3 | $50 |
| ABBVIE INC. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
Products named: TRELEGY ELLIPTA, REPATHA, Ozempic, NURTEC ODT, BREZTRI, FARXIGA, AIRSUPRA, Wegovy.
Industry payments across NC — which companies pay providers there.
